treatments for relapsed/refractory her2 breast cancer
Published 4 years ago • 37 plays • Length 4:44Download video MP4
Download video MP3
Similar videos
-
3:20
unmet needs in relapsed/refractory her2 breast cancer
-
6:23
treatment strategies for relapsed/refractory her2 mbc
-
19:20
fda-approved therapies for relapsed/refractory her2 mbc
-
3:44
relapsed/refractory her2 mbc: future treatment landscape
-
5:59
trastuzumab deruxtecan for the treatment of her2 breast cancer
-
6:35
treatment for high- and low-risk her2 breast cancer
-
6:46
treatment options in her2 metastatic breast cancer
-
0:59
sequencing her2-targeted therapies in breast cancer
-
3:22
managing recurrent metastatic er /her2- breast cancer
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
5:46
use of her2-targeted therapy in breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
4:30
tucatinib for the treatment of her2 breast cancer
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
1:26
targeted therapy for her2-positive breast cancer animation
-
4:09
selecting her2-targeted therapy for early breast cancer
-
1:16
the optimal duration of pertuzumab treatment for patients with her2 breast cancer
-
2:38
options in breast cancer after her2 targeted therapy